Search
Close this search box.

Clinical Trial: ALLIANCE A051902

ALLIANCE A051902

Status: Open

A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

A051902 is open to accrual to the Randomized Phase II Safety check portion of the study, effective September 18. 2023.